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portant role in the negative feedback mechanism of COX-215-Deoxy-12,14-prostaglandin J2 inhibits IL-1–induced cyclo-
expression in renal inflammation and may be useful as an anti-oxygenase-2 expression in mesangial cells.
inflammatory agent.Background. Cyclooxygenase-2 (COX-2), a key enzyme in
the synthesis of prostaglandins, is induced in mesangial cells
in response to proinflammatory cytokines. Recently, 15-deoxy-
12,14-prostaglandin J2 (15d-PGJ2), one of the natural ligands of Glomerular mesangial hyperplasia is one of the patho-peroxisome proliferator-activated receptor  (PPAR), has
logical characters in various glomerular diseases. On acti-been reported to have an anti-inflammatory effect. Therefore,
we examined the effect of 15d-PGJ2 on COX-2 expression in vation, mesangial cells are able to proliferate, produce
cultured rat mesangial cells. extracellular matrix proteins, and release numerous cyto-
Methods. Mesangial cells were incubated with 15d-PGJ2 for kines, growth factors, and prostaglandins [1, 2], suggest-30 minutes and then exposed to interleukin-1 (IL-1). The
ing that mesangial cells play an important role in theexpression of COX-2 mRNA and proteins was determined by
Northern blot and immunoblot analyses, respectively. Accu- process of glomerular damage.
mulation of prostaglandin E2 (PGE2) was measured by an en- Interleukin-1 (IL-1) is an immunoregulatory and pro-
zyme-linked immunosorbent assay (ELISA). Activities of mi- inflammatory cytokine released by various cells in re-
togen-activated protein kinases (MAPKs) were evaluated by
sponse to diverse extracellular stimuli, such as infection,an immunoblot analysis. DNA binding activities of activator
inflammation, cell injury, and toxins [3]. IL-1, producedprotein-1 (AP-1) or nuclear factor-B (NF-B) were examined
by an electrophoretic mobility shift assay (EMSA). The activi- by both infiltrating macrophages and activated mesan-
ties of PPAR responsive elements (PPRE) and COX-2 pro- gial cells in glomerulonephritis, is able to stimulate the
moter were measured by a luciferase reporter assay. production of prostaglandins and nitric oxide (NO) inResults. 15D-PGJ2 significantly suppressed IL-1–induced mesangial cells [4, 5]. Prostaglandins are arachidonic acidCOX-2 expression and PGE2 production, but thiazolidinedi-
metabolites that influence various cellular functions, in-ones, synthetic PPAR ligands, did not affect COX-2 expres-
sion. Moreover, the cells transfected with a PPRE luciferase cluding inflammation and cell proliferation [6], suggest-
reporter did not respond to 15d-PGJ2. IL-1 rapidly activated ing that prostaglandins induced by IL-1 may contribute
extracellular signal-regulated kinase (ERK) and c-Jun NH2- to the process of glomerular injury. Cyclooxygenase (COX)terminal kinase (JNK), which were involved in the up-regula-
is a key enzyme that catalyzes oxygenation in prostaglan-tion of COX-2 induction, but 15d-PGJ2 inhibited the activa-
din synthesis. COX converts arachidonic acid to prosta-tion of these kinases. 15d-PGJ2 inhibited the IL-1–induced
increase in binding activities of nuclear proteins to consen- glandin G2 (PGG2) and subsequently reduces PGG2 to
sus AP-1 site and AP-1–like site of COX-2 promoter but not of prostaglandin H2 (PGH2), which is further metabolized toNF-B. IL-1 was unable to activate the COX-2 promoter
the biologically active prostanoids, PGD2, PGE2, PGF2,when the AP-1–like site was mutated.
PGI2, and thromboxane A2 (TXA2) by their respectiveConclusions. These data suggest that 15d-PGJ2 inhibits IL-1–
induced COX-2 expression, independent of PPAR activa- synthases [6, 7]. Two COX isoforms, COX-1 and COX-2,
tion, by suppression of ERK and JNK pathways and AP-1 have been identified [8]. COX-1 is a constitutive form
activation in mesangial cells. Thus, 15d-PGJ2 may play an im- and present in various types of cells and tissues. COX-2
is an inducible form, undetectable at baseline in normal
tissues, and expressed by various stimuli, such as inflam-Key words: 15d-PGJ2, COX-2, mitogen-activated protein kinases, acti-
vator protein-1, glomerular mesangial cells, anti-inflammatory. matory cytokines and growth factors, followed by the
overproduction of prostanoids [9]. In mesangial cells,
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The peroxisome proliferator-activated receptor  (Osaka, Japan), respectively. Anti-COX-2 polyclonal an-
tibody and prostaglandin E2 EIA kits were purchased(PPAR) is a member of a nuclear hormone receptor
superfamily of ligand dependent transcription factors from Cayman Chemical (Ann Arbor, MI, USA). Anti-
phospho p42/p44 ERK, anti-phospho p38 MAPK and[17]. PPAR forms a heterodimer with retinoid X recep-
tor and the complex bind to a PPAR responsive element anti IB- antibodies, and PD 98059 were bought from
New England Biolabs (Beverly, MA, USA). Consensus(PPRE) in the promoter of target genes [17]. PPAR is
expressed at high levels in adipose tissue and is a critical oligonucleotides of AP-1 and NF-B, anti-phospho JNK
antibody, and U 0126 were purchased from Promegaregulator of adipocyte differentiation and glucose me-
tabolism [18]. PPAR is activated by synthetic ligands, (Madison, WI, USA). Anti-ERK 2, JNK 1, and p38
MAPK antibodies were obtained from Santa Cruz Bio-thiazolidinediones [19] (such as troglitazone and pioglita-
zone), and by a potent natural ligand 15-deoxy-12,14- technology (Santa Cruz, CA, USA). [-32P] dCTP and
[-32P] ATP were bought from New England Nuclearprostaglandin J2 (15d-PGJ2) [20, 21]. 15D-PGJ2 is a natu-
ral metabolite derived from PGD2, which is the most (Boston, MA, USA). Rat COX-2 cDNA (bases 1229-
1813) was prepared by reverse transcription with theabundant prostaglandin in normal tissues, and has the
highest binding affinity to PPAR in the J-series prosta- polymerase chain reaction (RT-PCR) from mRNA of
rat kidney as previously described [34], and the cDNAglandins [22]. 15D-PGJ2 has been shown to inhibit the
production of inflammatory cytokines and inducible ni- fragment was subcloned into pCR II vector with a TA
cloning kit (Invitrogen, Groningen, Netherlands). Alltric oxide synthase (iNOS) in activated peripheral mono-
cytes and macrophages [23, 24]. The anti-inflammatory other reagents were of chemical grade and purchased
from standard suppliers.effect of 15d-PGJ2 also has been found even in the non-
immune cells such as vascular smooth muscle cells
Mesangial cell culture and experimental procedure[25, 26] and endothelial cells [27].
Although several studies have shown that the anti- Glomerular mesangial cells were obtained from a cul-
ture of glomeruli that were isolated from six-week-oldinflammatory effect of 15d-PGJ2 appears to be regulated
through transcriptional inhibition by a PPAR-depen- male Sprague-Dawley rats by a sieving method as pre-
viously described [35]. The isolated glomeruli were cul-dent mechanism [23, 24, 28], recent evidence suggests
that the function of 15d-PGJ2 also is regulated by a tured in RPMI 1640 medium containing 20% heat-
inactive fetal bovine serum (FBS), 100 U/mL penicillin,PPAR-independent pathway [29–33]. In fact, 15d-PGJ2
is able to suppress the cytokine production in PPAR- 100g/mL streptomycin, 5g/mL insulin, 5g/mL trans-
ferrin, and 5 ng/mL selenious acid. Cultured cells weredeficient macrophage [29] and to block LPS-induced
iNOS expression by a mechanism independent of PPAR identified as mesangial cells by morphological and bio-
chemical characters as previously described [36]. Cul-in microglial cell lines [31]. Furthermore, nuclear factor-B
(NF-B), a well-known inflammatory transcription fac- tured mesangial cells from the 4th to 10th passages were
used for the experiments. Subconfluent mesangial cellstor, is repressed by 15d-PGJ2 in a PPAR-independent
manner [32, 33]. were made quiescent by incubating with serum-free
RPMI 1640 medium supplemented with 0.2% FFA free-Therefore, we hypothesized that 15d-PGJ2 has an anti-
inflammatory action in mesangial cells. To prove this bovine serum albumin (BSA) for 48 hours. Quiescent
cells were incubated with various concentrations ofhypothesis, we examined the effect of 15d-PGJ2 on
IL-1–induced COX-2 expression and PGE2 production IL-1 in an experimental medium (RPMI 1640 medium
with 0.2% BSA and 20 mmol/L HEPES, pH 7.4) for thein rat glomerular mesangial cells. We found that 15d-
PGJ2 partially inhibits IL-1–induced COX-2 expression indicated time intervals at 37C. For the experiments
with 15d-PGJ2, the cells were incubated with the indi-through the suppression of the MAPKs and AP-1 path-
ways. To our knowledge, the results of our study provide cated concentrations of 15d-PGJ2 for 30 minutes at 37C
prior to their exposure to IL-1. After the incubation, thethe first experimental evidence that 15d-PGJ2 has an
anti-inflammatory action via a PPAR-independent mech- cells were harvested for the determination listed below.
anism in mesangial cells.
Northern blot analysis
Total RNA (12 g) was isolated by guanidium and
METHODS
phenol extraction (TRIzol Reagent; Gibco BRL, Grand
Materials Island, NY, USA), electrophoresed on 1% formalde-
hyde-agarose gels, and transferred onto a nylon mem-Recombinant rat IL-1 was obtained from Sigma (St.
Louis, MO, USA). 15d-PGJ2 was bought from Calbio- brane (Nytran; Schleider & Schuell, Dassel, Germany).
Rat COX-2 cDNA was labeled with [-32P] dCTP by achem (La Jolla, CA, USA). Troglitazone and Pioglita-
zone were kindly provided by Sankyo Pharmaceutical random primer labeling method (Bca BEST; Takara,
Shiga, Japan). The membranes were hybridized with ratCo. (Tokyo, Japan) and Takeda Chemical Industries
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COX-2 cDNA in hybridization buffer [0.5 mol/L NaPO4, amplified a 386 bp fragment [26]. The primers for GAPDH,
pH 7.0, 1% BSA, 7% sodium dodecyl sulfate (SDS), used as control, were 5-GGTCGGTGTCAACGGAT
and 1 mmol/L ethylenediaminetetraacetic acid (EDTA)] TTG-3 and 5-GGCATGTCAGATCCACAACG-3,
at 65C for 16 hours. The membranes were autoradio- and then amplified a 728 bp fragment. The resulting
graphed with screens at 	80C overnight and rehybrid- products were separated on a 1.5% agarose gel and
ized with a radioactive probe of acidic ribosomal phos- stained with ethidium bromide.
phoprotein PO (36B4) cDNA as an internal standard [37].
Plasmids
Immunoblot analysis The AOx-TK-luciferase reporter construct containing
Mesangial cells were rinsed twice with ice-cold PBS three PPAR-responsive elements (PPRE3-TK-lucifer-
and lysed in 400 L ice-cold lysis buffer containing 150 ase) and PPAR expression plasmid were generously
mmol/L NaCl, 50 mmol/L Tris-HCl (pH 8.0), 0.1% SDS, provided by Dr. Christopher K. Glass (University of
1% Nonidet P-40. The cell lysates were centrifuged at California) [24]. To construct a reporter of the rat COX-2
15,000 rpm for 10 minutes after sonication and the super- promoter, a fragment of rat COX-2 promoter (bases
natants were collected. The concentrations of the protein 	373/
24) was amplified by polymerase chain reaction
in the supernatants were measured by the Bradford (PCR) with the use of rat genomic DNA as a template,
method (Bio-Rad, Hercules, CA, USA) and the cell ly- and the product was subcloned into a luciferase expres-
sates containing 40g protein were boiled in SDS sample sion vector, PGL2 basic (Promega) at MluI-XhoI sites,
buffer [62.5 mmol/L Tris-HCl, pH 6.8, 2% SDS, 10% as previously described [16]. Since one AP-1–like region
glycerol, 5% 2-mercaptoethanol, 50 mmol/L dithiothrei- was detected on the rat COX-2 promoter [38], a mutation
tol (DTT), 0.1% bromophenol blue] for five minutes. of this AP-1–like site was made by a PCR based site di-
The samples were electrophoresed on 10% SDS-poly- rected mutagenesis (Stratagene, La Jolla, CA, USA) us-
acrylamide gels and electrotransferred onto polyvinyli- ing a pair of oligonucleotides (	173/	147) substituted
dene difluoride (PVDF) membranes (Immobilon; Milli- CTCATTTGCGTGAGTAAAGCCTGCCCC for CTC
pore, Bedford, MA, USA). After blocking with TBS-T ATTTGCGTGACCTGAGCCTGCCCC. The sequence
(Tris buffered saline containing 0.1% Tween 20) con- authenticity of these plasmids was confirmed by a rhoda-
taining 5% nonfat milk, the membranes were incubated mine terminator cycle sequence system (ABI) and an ABI
with 1:1000 diluted anti-COX-2 polyclonal antibody or PRISM 310 genetic analyzer (Foster City, CA, USA).
anti-IB antibody at 4C overnight. The membranes
were washed three times and incubated with 1:1000 di- Transient transfection and luciferase assay
luted horseradish peroxide (HRP) conjugated-anti-rab-
When the mesangial cells were subconfluent on a six-bit secondary antibody (Amersham, Buckinghamshire,
well plate, the medium was replaced with serum-freeUK) at room temperature for one hour. The immunore-
RPMI 1640. The cells were then transfected with 0.3 gactive bands were detected with an enhanced chemilumi-
of the PPRE3-TK-luciferase plasmid reporter (PPRE-nescence (ECL) detection system (NEN Life Science
luc), 0.1g of the pCMV-Lac-Z plasmid, and either 0.8gProducts, Boston, MA, USA).
of the PPAR expression vector or a control vector
(pcDNA3; Invitrogen) by LipofectAMINE-plus reagentsMeasurement of prostaglandin E2 levels
(Gibco-BRL, Rockville, MD, USA). Three hours afterThe culture medium of mesangial cells on a six-well
transfection, the cells were starved in RPMI 1640 withplate was collected and stored at 	80C until assay. Ac-
0.2% BSA for 24 hours followed by the stimulation withcumulation of PGE2 in the medium was measured with
15d-PGJ2 for 16 hours. After washing twice with colda PGE2 enzyme-linked immunosorbent assay (ELISA)
phosphate-buffered saline (PBS), cells were harvestedkit. The concentrations of PGE2 were corrected with the
in 200 L of a reporter lysis buffer (Promega). Twentytotal amount of cellular proteins.
microliter aliquots of extracts were used to measure lucif-
Reverse transcription-polymerase chain erase activity by Luciferase Assay System (Promega) and
reaction (RT-PCR) a luminometer (Auto LUMIcounter Nu1422ES; Nition,
Tokyo, Japan). Co-transfected -galactosidase activityFor RT-PCR analysis, total RNA (200 ng) was reverse
was determined to normalize the luciferase activity.transcribed with random hexamers using the Gene-Amp
Similarly, cells were transfected with either 0.8 g ofRNA-PCR kit (Perkin-Elmer, Branchburg, NJ, USA)
the pGL2-COX2 or pGL2-COX2–mutant plasmid re-following the manufacturer’s directions. The cycling con-
porter gene. The cells were incubated with or withoutditions were 30 cycles of 15 seconds at 94C, 30 seconds
10 mol/L 15d-PGJ2 for 30 minutes and then stimulatedat 58C, and 45 seconds at 72C. The primers for rat
with IL-1 for 24 hours. Luciferase and -galactosidasePPAR were 5-AACCGGAACAAATGCCAGTA-3
and 5-TGGCAGCAGTGGAAGAATCG-3, and then activities were determined as described above.
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Fig. 1. Interleukin-1 (IL-1) induces cyclo-
oxygenase-2 (COX-2) expression in mesangial
cells. (A) Time course of the COX-2 mRNA
induction. Mesangial cells were incubated
with IL-1 (1000 pg/mL) for the indicated
time periods. Isolated total RNA (12 g)
was subjected to Northern blot analysis and
hybridized with COX-2 and 36B4 cDNA as
an internal control. (B) Dose dependency of
IL-1–induced COX-2 mRNA expression.
Mesangial cells were treated with various con-
centrations of IL-1 from 10 pg/mL to 5000
pg/mL for 2 hours. (C ) Time course of the
COX-2 protein induction. Mesangial cells
were incubated with IL-1 (1000 pg/mL) for
the indicated time periods. Whole cell lysates
were subjected to immunoblot analysis with
anti-COX-2 antibody. The results are repre-
sentative of five independent experiments that
yielded similar results.
Measurement of the activities of ERK, JNK minutes. The reaction mixtures were electrophoresed on
a 4% polyacrylamide gel and autoradiographed.and p38 MAPK
Activities of ERK, JNK, and p38 MAPK were deter-
Statistical analysis
mined by measuring the levels of phosphorylation of
The data were expressed as means  SD. Analysis ofeach kinase by immunoblot analysis. For the assay, mes-
variance (ANOVA) followed by Scheffe’s test was usedangial cell lysates were electrophoresed on 12% SDS-
to determine significant difference in multiple compari-polyacrylamide gels and electrotransferred to PVDF
sons and statistical significance was defined as P  0.05.membranes. After blocking with TBS-T and 5% BSA, the
membranes were probed with anti-phospho ERK, phos-
pho JNK, or phospho p38 MAPK antibodies as described RESULTS
above. The membranes were reprobed with anti-ERK2,
Effect of 15d-PGJ2 on IL-1–induced COX-2JNK1, or p38 MAPK antibodies as an internal control.
expression and PGE2 production
Nuclear extraction and electrophoretic mobility We first examined IL-1–induced expression of COX-2
shift assay (EMSA) in mesangial cells. IL-1 induced COX-2 mRNA expres-
sion after one hour with a maximal stimulation at fourMesangial cells were washed twice with ice-cold PBS
hours (Fig. 1A). IL-1was able to induce COX-2 mRNAand lysed by addition of a hypotonic buffer (10 mmol/L
in a dose-dependent manner with a maximal stimulationHEPES-KCl, pH 7.9, 1 mmol/L EDTA, 15 mmol/L KCl,
at 1000 pg/mL (Fig. 1B). COX-2 protein synthesis also2 mmol/L MgCl2, 1 mmol/L DTT and protease inhibitor
was stimulated by IL-1 with a maximum level at eightcocktail; Boehringer Mannheim, Lewes, UK) with 0.8%
hours (Fig. 1C).Nonidet P-40, and the lysates were centrifuged at 6000
To evaluate the effect of 15d-PGJ2 on COX-2 expres-rpm for 10 minutes. The pellets were resuspended in
sion, the cells were incubated with 15d-PGJ2 for 30 min-high salt buffer (hypotonic buffer with 420 mmol/L NaCl
utes prior to the stimulation with IL-1. The treatmentand 25% glycerol), rotated for 30 minutes at 4C and
with 15d-PGJ2 significantly suppressed IL-1–inducedcentrifuged at 15,000 rpm for 30 minutes. The superna-
COX-2 mRNA expression in a dose-dependent mannertants were used as nuclear extracts and the samples were
(Fig. 2A). Furthermore, IL-1–induced expression offrozen immediately in liquid nitrogen and stored at
COX-2 protein was partially inhibited by the treatment	80C until use. EMSAs were performed by incubating
with 10 mol/L 15d-PGJ2 (Fig. 2 B, C). In contrast, thethe nuclear proteins (4 g) with 1 g poly (dI-dC) in
synthetic ligands of PPAR, troglitazone (50 mol/L)binding buffer (10 mmol/L Tris, pH 7.5, 50 mmol/L NaCl,
and pioglitazone (10 mol/L), were unable to inhibit1 mmol/L DTT, 1 mmol/L EDTA, and 5% glycerol) at
IL-1–induced COX-2 mRNA expression (Fig. 2D) orroom temperature for 20 minutes and then reacted with
protein production (Fig. 2E). These results suggest that[-32P] ATP-end-labeled AP-1 or NF-B consensus oli-
15d-PGJ2 may act by a different mechanism from thiazol-gonucleotide, or COX-2 promoter oligonucleotide con-
taining the AP-1–like site at room temperature for 30 idinediones in mesangial cells.
Sawano et al: 15d-PGJ2 and COX-2 in mesangial cells 1961
Fig. 2. 15Deoxy-12,14-prostaglandin J2 (15D-
PGJ2) inhibits interleukin-1 (IL-1)–induced
COX-2 expression. (A) The cells were incu-
bated in the presence or absence of 15d-PGJ2
for 30 minutes and stimulated with 1000
pg/mL IL-1 for 4 hours. Total RNA (12 g)
was subjected to Northern blot analysis and
hybridized with COX-2 and 36B4 cDNA as an
internal control. The results of a densitometric
analysis of five independent experiments are
shown. *P  0.01 vs. control, UP  0.05 vs.
IL-1, #P  0.01 vs. IL-1. (B) The cells were
incubated in the presence or absence of 10
mol/L 15d-PGJ2 for 30 minutes and stimu-
lated with 1000 pg/mL IL-1 for 8 hours.
Whole cell lysates were subjected to immu-
noblot analysis with anti-COX-2 antibody.
(C ) The results of a densitometric analysis of
five independent immunoblot experiments are
shown. #P 0.01 vs. IL-1. (D) The cells were
pretreated with 50 mol/L troglitazone (Tro)
or 10mol/L pioglitazone (Pio) for 30 minutes
and stimulated with 1000 pg/mL IL-1 for 4
hours. Total RNA was subjected to Northern
blot analysis. (E) The cells were pretreated
with 50mol/L troglitazone (Tro) or 10mol/L
pioglitazone (Pio) for 30 minutes and stimu-
lated with 1000 pg/mL IL-1 for 8 hours.
Whole cell lysates of rat mesangial cells were
subjected to immunoblot analysis with anti-
COX-2 antibody. The results are representa-
tive of five independent experiments that
yielded similar results.
Next, the effect of 15d-PGJ2 on IL-1-induced produc-
tion of PGE2, which is one of the major products of
COX-2, was examined. PGE2 accumulation in the me-
dium increased about 15-fold by the stimulation of IL-1
for 24 hours. Similarly to the effect on COX-2 expression,
15d-PGJ2 significantly inhibited IL-1–induced produc-
tion of PGE2 in a dose-dependent manner (Fig. 3).
Effect of 15d-PGJ2 on PPAR activation
To determine whether 15d-PGJ2 was able to activate
PPAR, we first examined the expression of PPAR
mRNA in rat mesangial cells. Although RT-PCR re-
vealed the 386 bp band, which corresponded to PPAR
mRNA in rat mesangial cells, both IL-1 and 15d-PGJ2
failed to affect its expression (Fig. 4A). Moreover, we
found that in mesangial cells transfected with PPRE-luc
alone, 15d-PGJ2 failed to stimulate the reporter activity
in concentrations used in the present study (Fig. 4B).
However, the overexpression of PPAR increased basal
PPRE reporter activity and restored the ability of 15d- Fig. 3. 15D-PGJ2 attenuates prostaglandin E2 (PGE2) accumulation in
PGJ2 to induce it. response to IL-1. The cells were incubated in the presence or absence
of 15d-PGJ2 for 30 minutes and stimulated with 1000 pg/mL IL-1 for
24 hours. The culture media were collected and analyzed for PGE2Effect of 15d-PGJ2 on activation of NF-B
content. The data shown are mean  SD of five independent experi-
The transcription factor NF-B has been reported to ments that yielded similar results. *P  0.01 vs. control, #P  0.01 vs.
IL-1.play a role in the regulation of COX-2 gene expression
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Fig. 4. 15d-PGJ2 does not affect PPAR
mRNA expression and PPAR-dependent
transcription. (A) Cells were treated with IL-
1 for 4 hours in the presence or absence of
10 mol/L 15d-PGJ2. PPAR and GAPDH
mRNA expression were assessed by RT-PCR
of total RNA prepared from mesangial cells.
A representative one of five similar results is
shown. (B) Mesangial cells were co-trans-
fected with PPRE-luc plasmid and either con-
trol vector or PPAR expression vector, and
then treated with 15d-PGJ2 or control buffer
for 24 hours. Luciferase activity was measured
and normalized against -galactosidase activ-
ity. The results are expressed as relative light
units. The results are mean  SD of five inde-
pendent experiments.
Fig. 5. 15D-PGJ2 does not inhibit the degra-
dation of IB and the DNA binding activity
of nuclear factor-B (NF-B) by IL-1. The
cells were treated with 10 mol/L 15d-PGJ2
for 30 minutes and stimulated with 1000
pg/mL IL-1 for 60 minutes. (A) Whole cell
lysates of rat mesangial cells were subjected to
immunoblot analysis with anti-IB antibody.
(B) Nuclear extracts were prepared from the
cells and incubated with 32P-end labeled
NF-B consensus oligonucleotide probe and
subjected to a 4% polyacrylamide gel. The
arrow shows the specific binding of NF-B.
The results are representative of five indepen-
dent experiments that yielded similar results.
[39]. In resting cells, NF-B is localized in the cytoplasm expression [41–44]. Thus, we next examined the effect
by association with the inhibitory protein IB. In re- of 15d-PGJ2 on MAPK cascade activated by IL-1. To
sponse to inflammatory cytokine signals, IB kinase determine the role of ERK in IL-1–induced COX-2
(IKK) is activated and phosphorylates IB. Then, phos- expression, we first examined the effects of PD 98059
phorylated IB is degraded, and free NF-B migrates and U 0126, inhibitors of MAPK or ERK kinase (MEK),
into the nucleus and activates target gene expression [40]. on COX-2 protein production. As shown in Figure 6A,
Recent studies have indicated that 15d-PGJ2 inhibits treating the cells with 20 mol/L PD 98059 or U 0126
IKK activity and DNA binding activity of NF-B by a inhibited IL-1–induced COX-2 protein synthesis. Thus,
PPAR-independent mechanism [29, 30], and suppresses the ERK pathway is considered to be involved in
LPS-stimulated COX-2 expression in macrophages [28]. IL-1–induced COX-2 expression. The phosphorylation
Thus, we examined the effect of 15d-PGJ2 on NF-B of both p44 and p42 ERKs (ERK1 and ERK2) was
activation in mesangial cells. IL-1 induced IB degra- enhanced by IL-1 and the treatment with 15d-PGJ2dation and an increase in DNA binding activity of NF-B
resulted in a significant reduction in IL-1-induced phos-complex at 60 minutes. 15d-PGJ2 was unable to inhibit phorylation of ERK (Fig. 6B). We also examined theeither the IL-1–induced IB degradation (Fig. 5A) or
effect of 15d-PGJ2 on JNK and p38 MAPK pathwaysthe enhancement of DNA binding activity of NF-B
and found that 15d-PGJ2 was able to prevent the phos-(Fig. 5B).
phorylation of JNK by IL-1 (Fig. 6C), but the phosphor-
Effect of 15d-PGJ2 on IL-1–induced phosphorylation ylation of p38 MAPK was not inhibited by the treatment
of MAPKs of 15d-PGJ2 (Fig. 6D).
To determine whether de novo protein synthesis wasInterleukin-1 also was shown to activate MAPKs
and these kinases were found to play a role in COX-2 required in the inhibitory function of 15d-PGJ2 on ERK
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Fig. 6. 15D-PGJ2 suppresses IL-1–induced
activation of mitogen-activated protein ki-
nases (MAPKs). (A) The cells were treated
with 20 mol/L PD 98059 or U 0126 for 90
minutes, and stimulated with 1000 pg/mL
IL-1 for 8 hours. COX-2 protein production
was evaluated by immunoblot analysis with
anti-COX-2 antibody. A representative one
of five similar results is shown. (B) The cells
were incubated in the presence or absence 10
mol/L 15d-PGJ2 for 30 minutes and stimu-
lated with 1000 pg/mL IL-1 for 15 minutes.
The samples were electrophoresed on 12%
SDS-PAGE. The activities of ERK were eval-
uated by measuring the phosphorylation by
immunoblot analysis with anti-phospho ERK
antibody. After stripping, the membranes
were reprobed with anti-ERK2 antibody. A
representative one of five independent experi-
ments that yielded similar results is shown in
the upper panel. Densitometric quantification
of phosphorylated ERK2 was performed us-
ing NIH image software, and the ratio of phos-
phorylated ERK2 to total ERK2 is shown in
the lower panel. The data are expressed as
mean  SD (N  5). *P  0.01 vs. control,
#P  0.01 vs. IL-1. (C ) The activities of
JNK were evaluated with anti-phospho JNK
antibody and anti-JNK1 antibody. A repre-
sentative one of five results is shown in the
upper panel and the ratio of phosphorylated
JNK1 to total JNK1 is shown in the lower
panel. The data are expressed as mean  SD
(N  5). *P  0.01 vs. control, #P  0.05 vs.
IL-1. (D) The activities of p38 MAPK were
evaluated with anti-phospho p38 MAPK anti-
body and anti-p38 MAPK antibody. A repre-
sentative one of five results is shown.
and JNK pathway, the effects of cyclohexamide were
examined. 15d-PGJ2 could suppress the phosphorylation
of these kinases even in the presence of 10 g/mL cyclo-
hexamide (Fig. 7), indicating that the 15d-PGJ2–induced
down-regulation of ERK and JNK does not require de
novo protein synthesis.
Effect of 15d-PGJ2 on DNA binding activities of AP-1
Activated ERK and JNK enhance c-Fos expression
and c-Jun phosphorylation, respectively, and they are
found to form AP-1 heterodimers and enhance the DNA
binding activity [45–47]. Next, we examined the effect
of 15d-PGJ2 on its binding by using consensus AP-1 oli-
Fig. 7. De novo protein synthesis is not required for the inhibitory ef-gonucleotide. As shown in Figure 8A, IL-1 increased fect of 15d-PGJ2 on IL-1	induced activation of ERK and JNK. The
DNA binding activity of AP-1 complex at 60 minutes, cells were pretreated with 10 g/mL cyclohexamide (CHX) for 2 hours
and incubated in the presence or absence of 10 mol/L 15d-PGJ2 forand pre-treatment of the cells with 15d-PGJ2 partially
30 minutes. Afterwards, the cells were stimulated with 1000 pg/mL IL-1inhibited the IL-1–induced activation of DNA binding for 15 minutes. The activities of ERK and JNK were evaluated by immu-
noblot analysis. A representative one of five similar results is shown.activity of AP-1 in EMSA.
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Fig. 8. 15d-PGJ2 inhibits DNA binding activ-
ities of activator protein-1 (AP-1). The cells
were treated with 10 mol/L 15d-PGJ2 for 30
minutes and stimulated with 1000 pg/mL IL-1
for 60 minutes. (A) Nuclear extracts prepared
from the cells were incubated with 32P-end la-
beled AP-1 consensus oligonucleotide probe,
and then subjected to a 4% polyacrylamide
gel. The arrow shows the specific binding of
AP-1. A representative one of five results is
shown in the upper panel. The results of a
densitometric analysis of five independent ex-
periments are shown in the lower panel. *P 
0.01 vs. control, #P  0.01 vs. IL-1. (B) Nu-
clear extracts were incubated with 32P-end la-
beled COX-2 promoter oligonucleotide probe
containing AP-1–like site. A representative
one of five similar results is shown.
To confirm the AP-1 DNA binding in COX-2 pro-
moter, we next used 27 bp double-stranded oligonucleo-
tide (	173/	147) in rat COX-2 promoter containing the
AP-1–like sequence. Similarly to the results of Fig-
ure 8A, IL-1 enhanced the binding activities of nuclear
proteins to this AP-1–like site of COX-2 promoter, and
this binding was inhibited by 15d-PGJ2 (Fig. 8B). The
specific band was disappeared by the addition of excess
amount of either unlabeled AP-1 like oligonucleotide or
consensus AP-1 oligonucleotide.
Effect of 15d-PGJ2 on COX-2 promoter activity
To define the effect of 15d-PGJ2 on the COX-2 tran-
scription via the AP-1–like site, we transiently transfected
the cells with the rat COX-2 promoter construct (	373/

24) containing the AP-1–like site and examined rat Fig. 9. 15d-PGJ2 inhibits IL-1	induced COX-2 promoter activity.
Mesangial cells transfected with either 0.8g of the rat COX-2 promoterCOX-2 promoter activity. As shown in Figure 9, IL-1
(	373/
24) reporter plasmid (wt) or COX2-AP-1 like site mutant re-stimulated COX-2 promoter activity by 2.2-fold, and this porter plasmid (mt) were treated with 10 mol/L 15d-PGJ2 for 30
effect was partially inhibited by 15d-PGJ2, which did minutes and then incubated with or without 1000 pg/mL IL-1 for
24 hours. Luciferase activity was measured and normalized againstnot affect the basal COX-2 promoter activity. However,
-galactosidase activity. Results are expressed as relative light units.when the mutated COX-2 promoter construct was trans- The results are mean  SD of five independent experiments.
fected, the basal activity of COX-2 promoter activity
was reduced and IL-1 failed to stimulate this promoter
activity in mesangial cells (Fig. 9).
main prostaglandins catalyzed by COX-2 in the kid-
ney, also was inhibited by 15d-PGJ2. Furthermore, we
DISCUSSION found that 15d-PGJ2 inhibited IL-1–induced activation
of ERK, JNK, and AP-1, which could regulate COX-2This study clearly demonstrates that 15d-PGJ2 sup-
presses the IL-1–induced increase in the expression gene expression.
Cyclooxygenase-2, an inducible form of cyclooxygen-of mRNA and protein of COX-2 in glomerular mesangial
cells. IL-1–induced production of PGE2, one of the ase, is a key enzyme in prostaglandin synthesis and is
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known to play an important role in the process of glomer- gene expression [59] and plays an important role in the
signaling of various stimuli in mesangial cells [60–62].ular injury [48]. Thus, it is important to understand the
mechanism of the regulation of COX-2 expression in We and others have reported that IL-1 is able to acti-
vate ERK, JNK, and p38 MAPK [42–44, 62]. A previousglomerular mesangial cells, as these cells play a major
role in the pathological process of glomerular inflam- study suggested that the activation of both JNK and p38
is required for IL-1–induced COX-2 expression [44].mation. One of the primary products of COX is prosta-
glandin D2 (PGD2), which is rapidly and spontaneously Furthermore, by using the specific inhibitors of MEK,
we demonstrated that the activation of ERK pathway isconverted to PGJ2, 12PGJ2, and finally 15d-PGJ2 by
non-enzymatic dehydration. J-series prostaglandins have an important mechanism to mediate COX-2 expression
by IL-1. Recent studies have indicated that 15d-PGJ2unique biological effects, such as the suppression of viral
replication and inflammation [49]. Moreover, 15d-PGJ2 reduces IL-1–induced JNK phosphorylation in a rat insu-
linoma cell line [51] and LPS-induced ERK phosphoryla-is known to be one of the natural ligands of PPAR
[20, 21] and PPAR ligands were shown to have anti- tion in macrophages [63]. Since our study found that
15d-PGJ2 was able to inhibit IL-1–induced activationinflammatory actions in various cells [23, 24, 50, 51]. Re-
cent studies have reported that 15d-PGJ2 inhibits COX-2 of ERK and JNK pathways, the inhibition of these ki-
nases is one of the possible mechanisms of 15d-PGJ2.expression via PPAR-dependent manner in human epi-
thelial cells [52] and in macrophages [28], suggesting that 15-Deoxy-12,14-prostaglandin J2 and other PPAR li-
gands have been reported to induce the heat shock pro-15d-PGJ2 works as an intracellular mediator in negative
feedback loop of COX-2 through PPAR [28]. teins (HSPs) and heme oxygenase-1 (HO-1) [22, 50], and
the induction of these proteins has been proposed toWe first hypothesized that 15d-PGJ2 might have anti-
inflammatory effects through the activation of PPAR be associated with the inhibitory effect of 15d-PGJ2 on
signaling events. In rat islets, 15d-PGJ2 suppresses IL-1–in mesangial cells because several reports demonstrated
that PPAR was expressed in mesangial cells [53–58], induced JNK activation by inducing heat shock protein
70 [51]. In our study, 15d-PGJ2 was able to inhibit IL-1–and PPAR agonists were shown to modulate mesangial
cell proliferation and differentiation [53]. We showed induced activation of ERK and JNK even in the presence
of cyclohexamide. Thus, de novo protein synthesis includ-the presence of PPAR mRNA in rat mesangial cells
by RT-PCR method, but not by Northern blot analysis ing HSPs and HO-1 seems not to be required for the
inhibitory effect of 15d-PGJ2 on ERK and JNK pathways.(data not shown). We also demonstrated that 15d-PGJ2
or IL-1 did not affect PPAR mRNA expression. Al- Because IL-1 stimulated the DNA binding activity
of AP-1 [59, 62], we examined the effect of 15d-PGJ2 onthough our results clearly indicated that 15d-PGJ2 was
able to inhibit the IL-1–induced increase in the expres- the DNA binding activity of AP-1. We found that the
IL-1–induced increase in DNA binding activity of AP-1sion of mRNA and protein of COX-2 in mesangial cells,
PPAR synthetic agonists, troglitazone and pioglitazone, was inhibited by 15d-PGJ2 in mesangial cells. We also dem-
onstrated that both basal and IL-1–stimulated COX-2did not inhibit COX-2 expression. Furthermore, 15d-
PGJ2 could up-regulate PPRE luciferase activity in a promoter activities were reduced when the AP-1–like
site was mutated. Thus, these results implicate that 15d-dose-dependent manner only in PPAR-overexpressed
mesangial cells, and not in the cells transfected with PGJ2 inhibits IL-1–induced COX-2 expression by an
anti–AP-1 mechanism, providing an important PPAR-control vector. Thus, the action of 15d-PGJ2 on COX-2
expression and PGE2 production seems to be indepen- independent mechanism of 15d-PGJ2’s action.
A recent study reported that PPAR ligands can re-dent of its ability to activate PPAR in mesangial cells.
A possible PPAR-independent mechanism shown in duce phorbol ester-induced COX-2 by suppressing the
AP-1 activity, and one consequence of this anti–AP-1other cell types is the inhibition of IKK activity and
DNA binding activity of nuclear NF-B by 15d-PGJ2 effect is a competition for limiting the amounts of general
coactivator CBP/p300 [52]. Since the precise mechanism[29, 30]. A recent study indicated that the treatment of
human mesangial cells with 15d-PGJ2 blocked IL-1– of the action of PPAR ligands is not clarified yet, further
study is necessary to elucidate the precise mechanism ofinduced MCP-1 mRNA expression and protein pro-
duction by inhibiting the NF-B pathway [58]. However, the inhibitory effect of 15d-PGJ2 on MAPKs and AP-1
activation in mesangial cells.in our study, 15d-PGJ2 was not able to inhibit IL-1–
induced IB degradation and increase in DNA binding The selective COX-2 inhibitor, flosulide, has been re-
ported to decrease proteinuria in rats with Heymannactivity of NF-B, suggesting that the NF-B pathways
was not involved in the inhibitory effect of 15d-PGJ2 on nephritis [64, 65]. Furthermore, another COX-2 inhibi-
tor, SC 58236, has been shown to decrease proteinuriathe COX2 expression in rat mesangial cells.
The MAPK family of serine/threonine protein kinases and inhibit the development of glomerular sclerosis in
rats with reduced kidney mass [66]. These data suggestis a vital signaling mechanism that transmits signals from
the cell surface to the nucleus to ultimately regulate that the suppression of COX-2 might be useful for treat-
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